This stabilized HIF-α activates the transcription of proangiogenic factors and cell cycle regulators, driving the pathogenesis of VHL-associated neoplasms such as renal cell carcinoma (RCC), central nervous system (CNS) haemangioblastomas, and pancreatic neuroendocrine tumours. Here, VHL is linked to neoplasm.